By Gurkan Camok, MSc, Clinical Decision Support Systems Developer, Anadolu Medical Center / Johns Hopkins Medicine, Türkiye
LinkedIn: Gurkan Camok
LinkedIn: Anadolu Medical Center
Healthcare AI is often introduced through a performance metric: accuracy, sensitivity, specificity, or speed. Those measures matter, but hospital adoption is determined by a different question. Can the system deliver useful, understandable guidance inside a real clinical workflow without creating new delay, confusion, or risk?
A model can be technically excellent and still fail at the point of care. It may present a recommendation after the decision has already been made. It may send an alert to the wrong person, require data that are not reliably available, or identify risk without defining the action that should follow. It may also add another screen, login, or documentation step to a process that is already under pressure.
This is the workflow gap: the distance between generating an AI output and turning that output into a safe, timely, and accountable clinical action.
Accuracy Is Only the Starting Point
Clinical value depends on more than what an algorithm predicts. The Agency for Healthcare Research and Quality describes effective clinical decision support through the Five Rights: the right information, delivered to the right people, in the right format, through the right channel, and at the right time in the workflow. AI does not replace these principles. It makes them more important.
A high-performing prediction that arrives too late has little value. A recommendation that cannot be understood or acted on may be ignored. An alert that appears too often can become background noise. For healthcare organizations, the practical unit of success is not the prediction alone. It is the complete chain from data to decision to action.
Design Around Decisions, Not Features
Healthcare organizations should begin with the clinical decision, not the technology. What decision is being made? Who owns that decision? Which data are available at that moment? What action should follow? Which exceptions require escalation? Answering these questions before development can prevent a tool from becoming a technically impressive layer that sits outside the work it was meant to improve.
Workflow-native systems should reduce cognitive load rather than redistribute it. They should present only the information needed for the current decision, make the recommended action clear, and fit the existing sequence of care whenever possible. When a new step is unavoidable, its clinical purpose should be obvious to the user.
Build for Exceptions and Human Judgment
Real clinical environments contain missing data, conflicting information, urgent overrides, unusual patient characteristics, and cases that fall outside standard pathways. Safe AI implementation therefore requires more than a normal-path demonstration. Teams should test how the system behaves when data are incomplete, when recommendations conflict with clinical judgment, and when the user needs to override or escalate.
Transparency is central to this process. The ONC HTI-1 Final Rule established algorithm transparency requirements for predictive tools in certified health IT, while the FDA Clinical Decision Support Software guidance emphasizes the importance of whether healthcare professionals can independently review the basis for certain recommendations. In practice, users need relevant inputs, limitations, and a clear explanation of what the system is asking them to do.
Measure What Happens After the Output
Evaluation often ends with model performance, but deployment should be monitored as an ongoing clinical and operational process. Health systems should measure whether recommendations are seen, accepted, delayed, dismissed, or overridden. They should examine time to action, user burden, error rates, unintended consequences, and differences in performance across patient groups.
The NIST AI Risk Management Framework organizes responsible AI work around governance, mapping, measurement, and management. For healthcare, that lifecycle approach is essential. A tool that performed well during validation may behave differently after workflow changes, staffing changes, data drift, or broader deployment.
Frontline Teams Must Be Part of the Product Team
Clinicians, nurses, pharmacists, informaticians, quality and safety teams, and IT professionals should be involved before build, during simulation, and after deployment. Frontline participation is not a final usability check. It is how organizations discover where information is missing, where responsibility is unclear, and where a seemingly small design choice can create clinical risk.
Healthcare AI adoption will not be solved by more powerful models alone. It will advance when tools become workflow-native: placed at the right moment, connected to clinical protocols, transparent enough to review, designed for exceptions, and evaluated by what happens after the output appears.
Before deploying an AI system, healthcare leaders should ask not only, “How accurate is it?” They should also ask, “What exactly happens in the next five minutes after it produces an answer?” If that question has no clear response, the technology is not yet ready for routine care.